Summit Therapeutics Inc. Public Float
Summit Therapeutics Inc. (SMMT) had Public Float of $2.48 billion as of 2025-06-30, per its 10-K filed 2026-02-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-23
- 2025-06-30: Entity Public Float $2.48B.
- 2024-06-30: Entity Public Float $827.30M.
- 2023-06-30: Entity Public Float $108.40M.
- 2022-06-30: Entity Public Float $25.70M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.48B 10-K · filed 2026-02-23 |
| 2024-06-30 | $827.30M 10-K · filed 2025-02-24 |
| 2023-06-30 | $108.40M 10-K · filed 2024-02-20 |
| 2022-06-30 | $25.70M 10-K · filed 2023-03-09 |
| 2021-06-30 | $186.00M 10-K/A · filed 2022-12-21 |
| 2020-06-30 | $67.00M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |